News & Insights

Israel: A Loophole to Enhance Generics’ Ability to Launch At Risk During Patent Term Extension Protection Period

Live Virtual Event: Covid 19 Vaccines: Patent Rights Vs. Public Interest

COVID-19 Pandemic Webinar “The legal challenges and business opportunities in IP amid Coronavirus”

Israel Accelerates Examination of Patent Applications Relevant to the Fight Against Coronavirus

Circumventing Patents to Combat Covid-19 is Understandable But Does Not Encourage Innovation at a Time When Innovation is Needed Most, Argue Adv. Ephraim Heiliczer and Dr. Tal Sines

The Worldwide Stakes of Israeli Compulsory Licenses for Anti-Coronavirus Drugs

BPIP 2020 Tel Aviv!